NATCOPHARM2020-04-012020-06-30in-bse-fin:OneOperatingExpenses01Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue01Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue02Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults01Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults02Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets01Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets02Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities01Member NATCOPHARM2020-06-30in-bse-fin:OneReportableSegmentLiabilities01Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities02Member NATCOPHARM2020-06-30in-bse-fin:OneReportableSegmentLiabilities02Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss03Member NATCOPHARM2020-04-012020-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares NATCOPHARM 2020-04-01 2021-03-31 2020-08-03 INR Millions First quarter Multi segment 2020-04-01 2020-06-30 Unaudited Consolidated 5634000000.00 187000000.00 5821000000.00 1214000000.00 432000000.00 143000000.00 952000000.00 37000000.00 280000000.00 1182000000.00 4240000000.00 1581000000.00 0.00 1581000000.00 425000000.00 -65000000.00 360000000.00 0.00 1221000000.00 0.00 0.00 0.00 0.00 1221000000.00 21000000.00 1242000000.00 1228000000.00 -7000000.00 1249000000.00 -7000000.00 364000000.00 2 6.74 6.73 0.00 0.00 6.74 6.73 Where financial results contain both consolidated and standalone financial results of the parent, segment information is required to be presented only in the consolidated financial results. Accordingly, segment in formation has been presented in the consolidated financi al results. Others 1182000000.00 Agro chemicals 0.00 Phamaceuticals 5634000000.00 5634000000.00 0.00 5634000000.00 Agro chemicals 0.00 Phamaceuticals 1618000000.00 1618000000.00 37000000.00 0.00 1581000000.00 Agro chemicals 1610000000.00 Phamaceuticals 44871000000.00 46481000000.00 1305000000.00 47786000000.00 Agro chemicals 83000000.00 Phamaceuticals 4653000000.00 4736000000.00 3885000000.00 8621000000.00